Back to Agenda
Session 7: Hot Topics
Session Chair(s)
Arthur A. Levin, PhD
Distinguished Scientist, Avidity Biosciences, United States
The hot topics session is designed to provide the attendees with a glimpse at future oligonucleotide therapeutics. This session is a chance to see how the field is developing and what kind of novel approaches or applications are being studied in academia and industry. With this early look at these approaches, it is hoped that the audience can envision the promise of new technologies and have a preview of the kind of challenges these technologies will face or pose to the current regulatory environment.
Speaker(s)
Robert Ward
Chairman and CEO, Eloxx Pharmaceuticals, United States
Speaker
Jennifer Panagoulias, RAC
Regulatory Affairs and Compliance Consultant, Consultant, United States
Experience with FDA’s Complex Innovative Design (CID) Pilot
Charles R Allerson, PhD
VP of Chemistry and Drug Development, DTx Pharma, Inc., United States
Chantal Ferguson
MD/PhD Candidate, University of Massachusetts Medical School, United States
Potent siRNA Silencing in the Brain
Daniele Merico
Director of Molecular Genetics, Deep Genomics Inc., Canada
Have an account?